跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,628 条关于
“MeiraGTx Holdings plc”
全部
4,628
临床试验
891
药物
597
机构
1,877
资讯
1,263
去年
MeiraGTX's Gene Therapy Shows Promising Visual Benefits in Children with Rare Genetic Blindness
去年
MeiraGTx's AAV2-hAQP1 Receives FDA RMAT Designation for Radiation-Induced Xerostomia
去年
CRUK Receives $225 Million Investment; New CAR-T Cell Facility; Promising Gene Therapy for Parkinson's
7个月前
ZipBio and MeiraGTx Partner to Develop AI-Designed Gene Therapy for Geographic Atrophy
去年
MeiraGTx Advances Gene Therapy Pipeline with FDA RMAT Designation and Pivotal Trial Progress
去年
MeiraGTx's AAV-GAD Gene Therapy Shows Promise in Parkinson's Disease Phase I/II Trial
5个月前
MeiraGTx Reacquires Gene Therapy Botaretigene Sparoparvovec from Johnson & Johnson for X-linked Retinitis Pigmentosa Treatment
去年
MeiraGTx Unveils Breakthrough Gene Therapies for Obesity and Neurodegenerative Diseases at ASGCT 2025
去年
MeiraGTx and Hologen AI Form $430 Million Strategic Collaboration to Advance Parkinson's Disease Gene Therapy
5个月前
MeiraGTx Receives FDA Breakthrough Therapy Designation for Gene Therapy Treating Radiation-Induced Dry Mouth
第 1 页,共 127 页
上一页
下一页